United States · Series B startup

Who invested in Resolve Therapeutics

3 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$8.9Mraised across 3 rounds since 2011, from 3 sources

$2.0MSeries A$1.1MDebt$5.8MSeries B
Latest round
Series B, $5.8MNov 2012
Step-upi
5.4×
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2012
$2.0MSeries A$1.1MDebt$5.8MSeries B
First round
Series A, $2.0M
May 2011
Biggest round
$5.8M
Series B · Nov 2012
Usual gap between rounds
11 months
the median of 2

The rounds

  1. Nov 2012
    Series B$5.8M1 new2 returning

    Reported by finsmes.comSEC filing: $5.8M sold, first sale Nov 2012

  2. Apr 2012
    Debt$1.1M

    No investor was named in the report.

    Reported by sec.govSEC filing: $1.1M sold, first sale Apr 2012

  3. May 2011
    Series A$2.0M2 new

    Reported by xconomy.comSEC filing: $2.0M sold, first sale May 2011

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Resolve Therapeutics

Who invested in Resolve Therapeutics?

Resolve Therapeutics's investors include New Science Venture, Easton Capital and Washington Research Foundation.

How much has Resolve Therapeutics raised?

Resolve Therapeutics has raised $8.9M across 3 rounds since 2011.

When did Resolve Therapeutics last raise?

Resolve Therapeutics's most recent round was a Series B of $5.8M in Nov 2012.

What was Resolve Therapeutics's biggest round?

Its most recent round, $5.8M in Nov 2012, is also its largest on record.

Who backed Resolve Therapeutics first?

Resolve Therapeutics's first round on record, in May 2011, was backed by New Science Venture and Easton Capital.

What stage is Resolve Therapeutics at?

Resolve Therapeutics's latest named round is a Series B, in Nov 2012.

Where is Resolve Therapeutics based?

Resolve Therapeutics is based in the United States.

Companies like Resolve Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.